Posts Tagged ‘Carmel Milazzo Feil LLP’
Carmel, Milazzo & Feil LLP Represent Applied UV in a $5.75 Million Initial Public Offering
Carmel, Milazzo & Feil Obtain Successful Appeal and Vacatur of FINRA Disciplinary Finding
Press Release – New York, NY – April 13, 2020 – Securities and corporate law firm Carmel, Milazzo & Feil LLP announced today that attorneys Timothy Feil, Esq., and Craig Riha, Esq., obtained an appellate decision from the National Adjudicatory Council (“NAC”), the Financial Industry Regulatory Authority (“FINRA”) committee that reviews FINRA disciplinary proceedings, for their client…
Read MoreCarmel, Milazzo & Feil LLP Represents Co-Diagnostics In $4.2 Million Registered Direct Offering
Carmel, Milazzo & Feil LLP Represents Co-Diagnostics In $10.2 Million Registered Direct Offering
Carmel, Milazzo & Feil LLP Represents Co-Diagnostics In $5 Million Registered Direct Offering
CMF represents WallachBeth Capital in the IPO of Guardion Health Sciences Inc. on to the Nasdaq
CARMEL, MILAZZO & FEIL LLP REPRESENTS CTT PHARMACEUTICALS INC. IN $1,000,000 INVESTMENT FROM AURORA CANNABIS
Carmel, Milazzo & Feil LLP Represents Co-Diagnostics, Inc. (NASDAQ: CODX) in $7 Million Initial Public Offering (IPO)
Partner Ross D. Carmel Helps Ring the Closing Bell on Nasdaq with Long Island Iced Tea Corp. (Nasdaq: LTEA)
Partner Ross D. Carmel Helps Ring the Closing Bell on Nasdaq with Long Island Iced Tea Corp. (Nasdaq: LTEA) not assigned Carmel Milazzo Feil LLP | closing bell | cmf | nasdaq
Read MoreCarmel, Milazzo & Feil LLP Represents Network 1 Financial Securities, Inc. as Selling Agent and Alexander Capital L.P. as Selected Dealer in a $6.9 Million Public Offering and Uplisting to NASDAQ
